Future cardiology · 2026
Prognostic value of late gadolinium enhancement in peripartum cardiomyopathy: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nurhafizah Apridya, Huang Wilbert, Kezia Capella, Fathoni Muhammad Irfan, Zahrani Rivera Adenia Firza, Samban Sean Anthony, Atmojo Susetyo
Аннотация
BACKGROUND: Peripartum cardiomyopathy (PPCM) is a rare but life-threatening condition occurring during late pregnancy or the postpartum period. Although late gadolinium enhancement (LGE) has prognostic value in other cardiomyopathies, its role in PPCM remains unclear. This study aimed to evaluate the prognostic significance of LGE in PPCM.
METHODS: Three electronic databases were systematically searched to identify studies assessing the association between LGE and clinical outcomes in PPCM. Outcomes included reduced left ventricular ejection fraction (LVEF), arrhythmia, heart failure decompensation, device implantation, transplantation, and mortality. Pooled hazard ratios were calculated using the generic inverse variance method.
RESULTS: Eight cohort studies involving 227 patients were included. The mean age was 32.2 ± 6.6 years and mean LVEF was 30.5%. The pooled hazard ratio analysis revealed that LGE was significantly associated with poor outcomes (HR 1.34, CI 1.04-1.73 I2 = 52%, p = 0.02). Further analysis demonstrated that LGE was strongly linked to adverse clinical outcomes (HR 2.95, CI 1.62-5.37, I2 = 0%, p = 0.004), whereas no significant association was observed with persistently reduced LVEF (HR 1.11, CI 0.85-1.45, I2 = 14%, p = 0.45).
CONCLUSION: LGE is associated with poor outcomes in PPCM and may provide complementary prognostic value for risk stratification.
PROTOCOL REGISTRATION: www.crd.york.ac.uk/prospero identifier is CRD42024568502.
METHODS: Three electronic databases were systematically searched to identify studies assessing the association between LGE and clinical outcomes in PPCM. Outcomes included reduced left ventricular ejection fraction (LVEF), arrhythmia, heart failure decompensation, device implantation, transplantation, and mortality. Pooled hazard ratios were calculated using the generic inverse variance method.
RESULTS: Eight cohort studies involving 227 patients were included. The mean age was 32.2 ± 6.6 years and mean LVEF was 30.5%. The pooled hazard ratio analysis revealed that LGE was significantly associated with poor outcomes (HR 1.34, CI 1.04-1.73 I2 = 52%, p = 0.02). Further analysis demonstrated that LGE was strongly linked to adverse clinical outcomes (HR 2.95, CI 1.62-5.37, I2 = 0%, p = 0.004), whereas no significant association was observed with persistently reduced LVEF (HR 1.11, CI 0.85-1.45, I2 = 14%, p = 0.45).
CONCLUSION: LGE is associated with poor outcomes in PPCM and may provide complementary prognostic value for risk stratification.
PROTOCOL REGISTRATION: www.crd.york.ac.uk/prospero identifier is CRD42024568502.